Delays related to patient enrollment and difficulties related to patient retention may result in increased costs or may affect the timing or outcome of our future clinical trials, which could prevent completion of these trials and adversely affect our ability to advance the development of our product candidates
While this does not mean FDA approval yet, it is a big step in recognizing that regulators & lawmakers are engaging seriously with peptides instead of ignoring them
The global focus on metabolic wellness continues to accelerate as consumers prioritize sustainable weight management, blood-sugar awareness, and longevity-focused health strategies
And one thing that cannot be skipped
BPC-157 isnt magic, but its probably the closest thing weve got to speeding up repair without hopping in a cryo chamber or getting stem cell injections in Panama
The safety profile of our GLP-1 RAs is well established in robust clinical development programs and large real-world evidence studies with cumulative exposure to semaglutide alone, including post-marketing use, of over 22 million patient-years, the company added